During the past decade, University of Tennessee Cancer Institute conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 18 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Tennessee Cancer Institute" #1 sponsor was "SWOG Cancer Research Network" with 20 trials, followed by "Radiation Therapy Oncology Group" with 11 trials sponsored, "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "NSABP Foundation Inc" with 3 trials sponsored and "Novartis Pharmaceuticals" with 3 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Tennessee Cancer Institute" #1 collaborator was "National Cancer Institute (NCI)" with 47 trials as a collaborator, "SWOG Cancer Research Network" with 7 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator, "Eastern Cooperative Oncology Group" with 3 trials as a collaborator and "NCIC Clinical Trials Group" with 3 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "University of Tennessee Cancer Institute" are "Breast Cancer" (9 trials), "Lung Cancer" (9 trials), "Head and Neck Cancer" (6 trials), "Colorectal Cancer" (4 trials) and "Leukemia" (4 trials). Many other conditions were trialed in "University of Tennessee Cancer Institute" in a lesser frequency.

Most popular intervention types in "University of Tennessee Cancer Institute" are "Drug" (58 trials), "Biological" (15 trials), "Radiation" (15 trials), "Procedure" (13 trials) and "Other" (6 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (16 trials), "cisplatin" (10 trials), "paclitaxel" (8 trials), "filgrastim" (7 trials) and "conventional surgery" (6 trials). Other intervention names were less common.

The vast majority of trials in "University of Tennessee Cancer Institute" are 50 trials for "All" genders, 10 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "University of Tennessee Cancer Institute". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 53 completed trials in University of Tennessee Cancer Institute, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in University of Tennessee Cancer Institute, 2 "Phase 1" clinical trials were conducted, 33 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".